Clinical Trial Update: Safety Study of SPC3649 in Healthy Men [Phase 1]

View source ↗

Summary

Phase 1 safety study of SPC3649 in healthy men has completed. The trial, sponsored by Santaris Pharma A/S, pertained to Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SPC3649

Snippet

Sponsor: Santaris Pharma A/S | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED